VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $318,000 | +45.9% | 13,700 | 0.0% | 0.00% | +50.0% |
Q1 2018 | $218,000 | -59.3% | 13,700 | -71.7% | 0.00% | -60.0% |
Q1 2017 | $535,000 | -9.0% | 48,470 | +19.8% | 0.01% | 0.0% |
Q4 2016 | $588,000 | -40.8% | 40,470 | -0.0% | 0.01% | -37.5% |
Q3 2016 | $994,000 | -42.5% | 40,489 | -52.8% | 0.01% | -46.7% |
Q2 2016 | $1,728,000 | -20.3% | 85,789 | +4.0% | 0.02% | -28.6% |
Q1 2016 | $2,169,000 | -62.5% | 82,473 | +44.8% | 0.02% | -62.5% |
Q4 2015 | $5,791,000 | -34.8% | 56,973 | +14.4% | 0.06% | -39.8% |
Q3 2015 | $8,880,000 | -22.2% | 49,784 | -3.1% | 0.09% | -34.0% |
Q2 2015 | $11,415,000 | -25.7% | 51,384 | -16.3% | 0.14% | -19.0% |
Q1 2015 | $15,356,000 | +32.7% | 61,374 | -11.8% | 0.17% | +30.8% |
Q4 2014 | $11,574,000 | +111.7% | 69,584 | +67.0% | 0.13% | -9.5% |
Q3 2014 | $5,468,000 | -4.7% | 41,676 | -8.4% | 0.15% | -4.5% |
Q2 2014 | $5,735,000 | +15.0% | 45,476 | +32.7% | 0.15% | +2.7% |
Q1 2014 | $4,985,000 | +7.0% | 34,276 | -8.3% | 0.15% | -15.3% |
Q4 2013 | $4,658,000 | +36.1% | 37,376 | +17.3% | 0.18% | +19.6% |
Q3 2013 | $3,422,000 | -48.0% | 31,876 | -57.9% | 0.15% | -35.9% |
Q2 2013 | $6,584,000 | – | 75,700 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |